Log in to save to my catalogue

Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoart...

Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoart...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4112443

Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis

About this item

Full title

Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis

Publisher

England: Elsevier Limited

Journal title

Annals of the rheumatic diseases, 2014-08, Vol.73 (8), p.1558-1565

Language

English

Formats

Publication information

Publisher

England: Elsevier Limited

More information

Scope and Contents

Contents

Background Increased subchondral bone turnover may contribute to pain in osteoarthritis (OA). Objectives To investigate the analgesic potential of a modified version of osteoprotegerin (osteoprotegerin-Fc (OPG-Fc)) in the monosodium iodoacetate (MIA) model of OA pain. Methods Male Sprague Dawley rats (140–260 g) were treated with either OPG-Fc (3 m...

Alternative Titles

Full title

Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4112443

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4112443

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2013-203260

How to access this item